학술논문
Low on-treatment levels of serum soluble CD8 (sCD8) predict better outcomes in advanced non-small cell lung cancer patients treated with atezolizumab
Document Type
Article
Source
In: Cancer Immunology, Immunotherapy . (Cancer Immunology, Immunotherapy, June 2023, 72(6):1853-1863)
Subject
Language
English
ISSN
14320851
03407004
03407004